Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tatsuo Sezaki is active.

Publication


Featured researches published by Tatsuo Sezaki.


British Journal of Haematology | 2000

Human bone marrow stroma‐dependent cell line MOLP‐5 derived from a patient in leukaemic phase of multiple myeloma

Yoshinobu Matsuo; Hans G. Drexler; Chiharu Nishizaki; Akira Harashima; Shunichi Fukuda; Teruhiko Kozuka; Tatsuo Sezaki; Kunzo Orita

The novel multiple myeloma (MM) cell line MOLP‐5 and its homologous sister cell line B407, a lymphoblastoid cell line (LCL), were established from the peripheral blood of a 71‐year‐old Japanese patient with Bence‐Jones κ‐type multiple myeloma (stage IIIB with hyperammonaemia and hypercalcaemia). The growth of MOLP‐5 cells is constitutively dependent on bone marrow stroma (BST) cells; none of the cytokines tested nor the culture supernatant of the bone marrow stroma cells could support the growth of MOLP‐5. Wright–Giemsa‐stained MOLP‐5 cells showed typical plasma cell morphology with abundant cytoplasm and one to three nuclei. The immunoprofile of MOLP‐5 corresponds to that seen typically in primary MM cells: positive for cytoplasmic immunoglobulin (Ig) κ light chain, CD28, CD29, CD38, CD40, CD44, CD49d, CD54, CD56, CD58, CD71, CD138 and PCA‐1; the cells were negative for surface Ig and various other B‐cell, T‐cell and myelomonocyte‐associated immunomarkers. Interleukin 6 (IL‐6) receptor mRNA was found in the reverse transcriptase polymerase chain reaction (RT‐PCR) analysis. IL‐6 and IL‐10 could induce cellular proliferation in short‐term induction experiments. IL‐6 or IL‐10 production was not detected by specific enzyme‐linked immunoabsorbent assay (ELISA). MOLP‐5 cells expressed parathyroid hormone‐related protein (PTHrP) at the mRNA level. Cytogenetic analysis showed the typical t(11; 14) chromosome abnormality. The novel MOLP‐5 cell line together with the B407 B‐LCL sister line will be useful model systems in the investigation of the biology of MM.


Pathology International | 1976

Non-African Burkitt's lymphoma in a young woman.

Toshio Tanaka; Shokichi Komatsubara; Isao Miyoshi; Shunkichi Hieaki; Shinya Tada; Ichiro Kubonishi; Masashi Hujii; Tatsuo Sezaki

Non‐African Burkitts lymphoma is presented in a 29‐year‐old, unmarried woman, who developed tumors in both breasts and ovaries, ascites and pleural effusion. Assessment of B cells in the tumor cells, derived from ascites, pleural effusion and tumor tissue is 90%, surface IgM being consisted of 86%, in an average. Histologically, the tumor tissue demonstrates prominent, so‐called starry‐sky effect, and cytologically, tumor cells are poorly‐differentiated lymphocytoid ceUs in their features.


Pathology International | 1979

MACROGLOBULINEMIA WALDENSTRUM COMPLICATED BY AUTOIMMUNE HEMOLYTIC ANEMIA, MENINGEAL SIGN AND FEMORAL LYSIS

Toshio Tanaka; Nobuo Ueda; Mineji Fujita; Akira Oka; Shigeto Tanaka; Tatsuo Sezaki; Kuro Yamamoto; Humitoshi Shiomi

A necropsied case of macroglobulinemia Waldenström with unusual complications was presented; the patient was found to have autoimmune hemolytic anemia, first. During the course of its treatment, he developed monoclonal immunoglobulin M in serum together with lytic osseous lesion in both femurs, and died of meningeal involvement by tumor cells. Clinically, he had hepatosplenomegaly and generalized lymphadenopathy. The macroglobulin was kappa type of light chain, ultracentrifugation showed a sharp spike of 21S in 18.6%, and myelogram revealed increased lymphocytoid series of 29.6%. It was proved that autoantibody causing autoimmue hemolytic anemia was composed of IgG and macroglobulin itself had no activity as an anti‐red cell antibody. An emphasis was made that autoimmune hemolytic anemia followed by macroglobulinemia is based on the state of immunodeficiency of this patient.


Cancer Research | 1999

Decreases in Ikaros Activity Correlate with Blast Crisis in Patients with Chronic Myelogenous Leukemia

Hiroyuki Nakayama; Fumihiko Ishimaru; Nicole Avitahl; Nobuo Sezaki; Nobuharu Fujii; Koichi Nakase; Yoshifumi Ninomiya; Akira Harashima; Jun Minowada; Junjiro Tsuchiyama; Kenji Imajoh; Teruhiko Tsubota; Shunnichi Fukuda; Tatsuo Sezaki; Kensuke Kojima; Masamichi Hara; Hidetaka Takimoto; Seiichi Yorimitsu; Isao Takahashi; Akira Miyata; Shuichi Taniguchi; Yasunobu Tokunaga; Hisashi Gondo; Yoshiyuki Niho; Shinji Nakao; Taiichi Kyo; Hiroo Dohy; Nanao Kamada; Mine Harada


GANN Japanese Journal of Cancer Research | 1963

CELL-FREE TRANSMISSION OF 20-METHYLCHOLANTHRENE-INDUCED RF MOUSE LEUKEMIA AND ELECTRON MICROSCOPIC DEMONSTRATION OF VIRUS PARTICLES IN ITS LEUKEMIC TISSUE

Shozo Irino; Zensuke Ota; Tatsuo Sezaki; Masanori Suzaki; Kiyoshi Hiraki


Japanese Journal of Clinical Oncology | 1984

Aclarubicin in the Treatment of Multiple Myeloma

Tatsuo Sezaki; Tomiro Adachi; Hirofumi Ishii; Kenwo Asano; Isao Takahashi; Ikuro Kimura


Acta Medica Okayama | 1982

Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy

Tomiroh Adachi; Kenwo Asano; Tatsuo Sezaki; Isao Takahashi; Ikuro Kimura


Acta Medica Okayama | 1979

The tumor-forming type of multiple myeloma. II. Clinical profile and therapeutic effect.

Tatsuo Sezaki; Hujita M; Akira Oka; Toshio Tanaka


Acta Medica Okayama | 1973

A relationship of genetic type in serum haptoglobin with leukemia, malignant lymphoma and cancer.

Tatsuo Sezaki; Sanae Tanaka; Shozo Irino; Kiyoshi Hiraki


GANN Japanese Journal of Cancer Research | 1968

Organ distribution of 3-methylcholanthrene after repeated painting and oral administration in relation to the induction of leukemia in mice

Shozo Irino; Tatsuo Sezaki; Junichiro Moriya; Kiyoshi Hiraki

Collaboration


Dive into the Tatsuo Sezaki's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge